161 related articles for article (PubMed ID: 28587900)
21. Age-related alteration of emotional regulation in the BACHD rat model of Huntington disease.
Lamirault C; Nguyen HP; Doyère V; El Massioui N
Genes Brain Behav; 2020 Jun; 19(5):e12633. PubMed ID: 31883197
[TBL] [Abstract][Full Text] [Related]
22. Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.
Tan Z; Dai W; van Erp TG; Overman J; Demuro A; Digman MA; Hatami A; Albay R; Sontag EM; Potkin KT; Ling S; Macciardi F; Bunney WE; Long JD; Paulsen JS; Ringman JM; Parker I; Glabe C; Thompson LM; Chiu W; Potkin SG
Mol Psychiatry; 2015 Nov; 20(11):1286-93. PubMed ID: 26100538
[TBL] [Abstract][Full Text] [Related]
23. Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease.
Abada YS; Nguyen HP; Schreiber R; Ellenbroek B
PLoS One; 2013; 8(7):e68584. PubMed ID: 23874679
[TBL] [Abstract][Full Text] [Related]
24. Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease.
Soylu-Kucharz R; Baldo B; Petersén Å
Sci Rep; 2016 Jun; 6():28322. PubMed ID: 27334347
[TBL] [Abstract][Full Text] [Related]
25. Methyleugenol counteracts anorexigenic signals in association with GABAergic inhibition in the central amygdala.
Zhu T; Yan Y; Deng S; Liu YM; Fan HR; Ma B; Meng B; Mei B; Li WG; Li F
Neuropharmacology; 2018 Oct; 141():331-342. PubMed ID: 30170083
[TBL] [Abstract][Full Text] [Related]
26. The purinergic mechanism of the central nucleus of amygdala is involved in the modulation of salt intake in sodium-depleted rats.
Guan L; Qiao H; Wang N; Luo X; Yan J
Brain Res Bull; 2018 Oct; 143():132-137. PubMed ID: 30170187
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.
King AC; Wood TE; Rodriguez E; Parpura V; Gray M
Exp Neurol; 2020 Aug; 330():113358. PubMed ID: 32387649
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats.
Jiang H; Fang D; Kong LY; Jin ZR; Cai J; Kang XJ; Wan Y; Xing GG
Mol Brain; 2014 Oct; 7():72. PubMed ID: 25277376
[TBL] [Abstract][Full Text] [Related]
29. Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's Disease.
Osmand AP; Bichell TJ; Bowman AB; Bates GP
J Huntingtons Dis; 2016 Dec; 5(4):343-346. PubMed ID: 27886014
[TBL] [Abstract][Full Text] [Related]
30. Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.
Schroeder AM; Wang HB; Park S; Jordan MC; Gao F; Coppola G; Fishbein MC; Roos KP; Ghiani CA; Colwell CS
PLoS One; 2016; 11(1):e0147269. PubMed ID: 26807590
[TBL] [Abstract][Full Text] [Related]
31. Amygdaloid GABA, not glutamate neurotransmission or mRNA transcription controls footshock-associated fear arousal in the acoustic startle paradigm.
Van Nobelen M; Kokkinidis L
Neuroscience; 2006; 137(2):707-16. PubMed ID: 16289581
[TBL] [Abstract][Full Text] [Related]
32. Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease.
Cheong RY; Tonetto S; von Hörsten S; Petersén Å
Psychoneuroendocrinology; 2020 Sep; 119():104773. PubMed ID: 32590293
[TBL] [Abstract][Full Text] [Related]
33. Involvement of GABA
Dong N; Du P; Hao X; He Z; Hou W; Wang L; Yuan W; Yang J; Jia R; Tai F
Neuropeptides; 2017 Dec; 66():8-17. PubMed ID: 28764883
[TBL] [Abstract][Full Text] [Related]
34. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice.
Morozko EL; Ochaba J; Hernandez SJ; Lau A; Sanchez I; Orellana I; Kopan L; Crapser J; Duong JH; Overman J; Yeung S; Steffan JS; Reidling J; Thompson LM
J Huntingtons Dis; 2018; 7(4):321-335. PubMed ID: 30452420
[TBL] [Abstract][Full Text] [Related]
36. GABAA receptors in the central nucleus of amygdala (CeA) affect on pain modulation.
Hasanein P; Mirazi N; Javanmardi K
Brain Res; 2008 Nov; 1241():36-41. PubMed ID: 18838064
[TBL] [Abstract][Full Text] [Related]
37. BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.
Gu Y; Pope A; Smith C; Carmona C; Johnstone A; Shi L; Chen X; Santos S; Bacon-Brenes CC; Shoff T; Kleczko KM; Frydman J; Thompson LM; Mobley WC; Wu C
Neurobiol Dis; 2024 Jun; 195():106502. PubMed ID: 38608784
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
Ban JJ; Chung JY; Lee M; Im W; Kim M
Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory changes in peripheral organs in the BACHD murine model of Huntington's disease.
Valadão PAC; Oliveira BDS; Joviano-Santos JV; Vieira ÉLM; Rocha NP; Teixeira AL; Guatimosim C; de Miranda AS
Life Sci; 2019 Sep; 232():116653. PubMed ID: 31302194
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M
Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
